Multivariate analysis of risk factors for rejection
. | Hazard ratio (95% CI) . | P . |
|---|---|---|
| Hematopoietic cell source | ||
| G-PBMC, n = 71 | 1.0 | .003 |
| Marrow, n = 18 | 4.7 (1.8-12) | |
| Preceding chemotherapy | ||
| No, n = 24 | 1.0 | .003 |
| Yes, n = 65 | 0.2 (0.1-0.6) |
. | Hazard ratio (95% CI) . | P . |
|---|---|---|
| Hematopoietic cell source | ||
| G-PBMC, n = 71 | 1.0 | .003 |
| Marrow, n = 18 | 4.7 (1.8-12) | |
| Preceding chemotherapy | ||
| No, n = 24 | 1.0 | .003 |
| Yes, n = 65 | 0.2 (0.1-0.6) |
CI indicates confidence interval. All other abbreviations are explained in Table 1. Factors considered included diagnosis, hematopoietic cell source, disease type, CD34 dose, CD3 dose, patient sex, donor sex, sex mismatch, HLA class I mismatch, preceding transfusion, preceding chemotherapy, and prior autologous transplant.